Missing Data: Turning Guidance Into Action

Statistics in Biopharmaceutical Research

Volumn 5, Issue 4, 2013, Pages 369-382

  Mallinckrodt, Craig ^a   Roger, James ^b   Chuang stein, Christy ^c   Molenberghs, Geert ^d,e   Lane, Peter W ^f   O'kelly, Michael ^g   Ratitch, Bohdana ^g   Xu, Lei ^h   Gilbert, Steve ⁱ   Mehrotra, Devan V ^j   Wolfinger, Russ ^k   Thijs, Herbert ^d,e  

^a ELI LILLY AND COMPANY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PFIZER INC   (United States)

^d HASSELT UNIVERSITY   (Belgium)

^e KU LEUVEN   (Belgium)

^f GLAXOSMITHKLINE   (United Kingdom)

^g IQVIA   (United States)

^h BIOGEN   (United States)

ⁱ RHO INC   (United States)

^j MERCK RESEARCH LABORATORIES   (United States)

^k SAS INSTITUTE INC   (United States)

more..

Author keywords

Clinical trials; Longitudinal analyses; Sensitivity analyses

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MISSING DATA; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 84889688387     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2013.848822     Document Type: Article

References (32)

1. Carpenter, J. R. and Kenward, M. G. 2007. " Missing Data in Randomised Controlled Trials-A Practical Guide ". available at http://missingdata.lshtm.ac.uk/downloads/rm04_jh17_mk.pdf (accessed 23 January 2012)
2. Carpenter, J. R., Kenward, M. G. and Vansteelandt, S. 2006. A Comparison of Multiple Imputation and Doubly Robust Estimation for Analyses With Missing Data. Journal of the Royal Statistical Society, Series A, 169: 571 - 584.
3. Committee for Medicinal Products for Human Use (CHMP). 2010. " Guideline on Missing Data in Confirmatory Clinical Trials ". EMA/CPMP/EWP/1776/99 Rev. 1
4. Daniel, R. and Kenward, M. 2012. A Method for Increasing the Robustness of Multiple Imputation. Computational Statistics and Data Analysis, 56: 1624 - 1643.
5. Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C. and Demitrack, M. A. 2004. Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine. Journal of Clinical Psychopharmacology, 24: 389 - 399.
6. Guico-Pabia, C., Fayyad, R. and Soares, C. 2011. Assessing the Relationship Between Functional Impairment/Recovery and Depression Severity. International Clinical Psychopharmacology, 27: 1 - 7.
7. Hamilton, M. 1960. A Rating Scale for Depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23: 56 - 61.
8. Khan, A., Schwartz, K., Redding, N., Kolts, R. and Brown, W. A. 2007. Psychiatric Diagnosis and Clinical Trial Completion Rates: Analysis of the FDA SBA Reports. Neuropsychopharmacology, 32: 2422 - 2430.
9. Kim, Y. 2011. Missing Data Handling in Chronic Pain Trials. Journal of Biopharmaceutical Statistics, 21: 311 - 325.
10. Lane, P. W. 2008. Handling Drop-out in Longitudinal Clinical Trials: A Comparison of the LOCF and MMRM Approaches. Pharmaceutical Statistics, 7: 93 - 106.
11. Little, R. and Yau, L. 1996. Intention-to-Treat Analysis for Longitudinal Studies With Drop-Outs. Biometrics, 52: 1324 - 1333.
12. Little, R. J. A. and Rubin, D. B. 2002. Statistical Analysis with Missing Data, (2nd ed.), New York: Wiley.
13. Mallinckrodt, C. H. and Kenward, M. G. 2009. Conceptual Considerations Regarding Choice of Endpoints, Hypotheses, and Analyses in Longitudinal Clinical Trials. Drug Information Journal, 43: 449 - 458.
14. Mallinckrodt, C. H., Lane, P. W., Schnell, D., Peng, Y. and Mancuso, J. P. 2008. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal, 42: 305 - 319.
15. Mallinckrodt, C. H., Lin, Q., Lipkovich, I. and Molenberghs, G. 2012. A Structured Approach to Choosing Estimands and Estimators in Longitudinal Clinical Trials. Pharmaceutical Statistics, 11: 456 - 461.
16. Mallinckrodt, C. H., Raskin, J., Wohlreich, M. M., Watkin, J. G. and Detke, M. J. 2004. The Efficacy of Duloxetine: A Comprehensive Summary of Results From MMRM and LOCF in Eight Clinical Trials. BMC Psychiatry, 4: 26
17. Mergl, R., Henkel, V., Allgaier, A., Kramer, D., Hautzinger, M., Kohnen, R., Coyne, J. and Hegerl, U. 2011. Are Treatment Preferences Relevant in Response to Serotonergic Antidepressants and Cognitive-Behavioral Therapy in Depressed Primary Care Patients? Results From a Randomized Controlled Trial Including a Patients' Choice Arm, Psychother. Psychosomatic, 80: 39 - 47.
18. Molenberghs, G. and Kenward, M. G. 2007. Missing Data in Clinical Studies, Chichester: Wiley.
19. Molenberghs, G., Thijs, H., Jansen, I., Beunckens, C., Kenward, M. G., Mallinckrodt, C. H. and Carroll, R. J. 2004. Analyzing Incomplete Longitudinal Clinical Trial Data. Biostatistics, 5: 445 - 464.
20. National Research Council. 2010. " The Prevention and Treatment of Missing Data in Clinical Trials. Panel on Handling Missing Data in Clinical Trials. Committee on National Statistics, Division of Behavioral and Social Sciences and Education ". Washington, DC: The National Academies Press.
21. O'Neill, R. T. and Temple, R. 2012. The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It. Clinical Pharmacology and Therapeutics, 91: 550 - 554. doi: 10.1038/clpt.2011.340
22. Permutt, T. and Pinheiro, J. 2009. Dealing With the Missing Data Challenge in Clinical Trials. Drug Information Journal, 43: 403 - 408.
23. Ratitch, B. and O'Kelly, M. 2011. Implementation of Pattern-Mixture Models Using Standard SAS/STAT Procedures. PharmaSUG, Available at http://pharmasug.org/proceedings/2011/SP/PharmaSUG-2011-SP04.pdf (accessed October 4, 2011)
24. Robins, J. M., Rotnizky, A. and Zhao, L. P. 1994. Estimation of Regression Coefficients When Some Regressors are not Always Observed. Journal of the American Statistical Association, 89: 846 - 866.
25. Robins, J. M., Rotnizky, A. and Zhao, L. P. 1995. Analysis of Semiparametric Regression Models for Repeated Outcomes in the Presence of Missing Data. Journal of the American Statistical Association, 90: 106 - 121.
26. Roger, J., Ritchie, S., Donovan, C. and Carpenter, J. Sensitivity Analysis for Longitudinal Studies With Withdrawal. PSI Conference, Abstract at http://www.psiweb.org/docs/2008finalprogramme.pdf (accessed 23 January 2012)
27. Rubin, D. B. 1987. Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
28. SAS Institute Inc. 2008. SAS/STAT® 9.2. User's Guide, Cary, NC: SAS Institute Inc.
29. Siddiqui, O., Hung, H. M. and O'Neill, R. O. 2009. MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets. Journal of Biopharmaceutical Statistics, 19: 227 - 246.
30. Teshome, B., Lipkovich, I., Molenberghs, G. and Mallinckrodt, C. H. 2013. Placebo Multiple Imputation: A New Approach to Sensitivity Analyses for Incomplete Longitudinal Clinical Trial Data. Submitted
31. Tsiatis, A. A. 2006. Semiparametric Theory and Missing Data, New York: Springer.
32. Verbeke, G. and Molenberghs, G. 2000. Linear Mixed Models for Longitudinal Data, New York: Springer.